Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

4D Molecular Therapeutics, Inc. FDMT

Full chart Compare
Set alert

Price alert · FDMT

All alert types
11.88 USD +0.51 (+4.49%)

Nov 3, 2026, 3:43 PM EST

11.46 Day range 12.08
6.96 52-week range 16.93
YTD
+58.40%
1 year
+5.88%

Financial health

Altman Z-Score

1.71 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -3.1×
FY 2017: -53.3×FY 2018: -53.3×FY 2019: -20.3×FY 2020: -19.6×FY 2021: -8.9×FY 2022: -7.1×FY 2023: -7.9×FY 2024: -1.9×FY 2025: -3.1×
FY 2017 5y median -7.1× FY 2025
P/S 5.1×
FY 2017: 104×FY 2018: 35.9×FY 2019: 154×FY 2020: 81.2×FY 2021: 33.7×FY 2022: 230×FY 2023: 38.3×FY 2024: 8121×FY 2025: 5.1×
FY 2017 5y median 38.3× FY 2025
P/B 0.9×
FY 2017: -30.7×FY 2018: -18.4×FY 2019: -14.7×FY 2020: 4.3×FY 2021: 1.9×FY 2022: 3.1×FY 2023: 2.6×FY 2024: 0.6×FY 2025: 0.9×
FY 2017 5y median 1.9× FY 2025
P/FCF -4.0×
FY 2017: 78.4×FY 2018: -30.4×FY 2019: -26.9×FY 2020: -21.3×FY 2021: -7.8×FY 2022: -7.3×FY 2023: -10.1×FY 2024: -2.2×FY 2025: -4.0×
FY 2017 5y median -7.3× FY 2025
EV/EBITDA -3.0×
FY 2017: -54.2×FY 2018: -42.8×FY 2019: -22.9×FY 2020: -15.0×FY 2021: -6.9×FY 2022: -6.6×FY 2023: -5.9×FY 2024: -1.1×FY 2025: -3.0×
FY 2017 5y median -5.9× FY 2025
EV/Sales 4.6×
FY 2017: 99.7×FY 2018: 29.4×FY 2019: 146×FY 2020: 60.9×FY 2021: 26.2×FY 2022: 218×FY 2023: 26.9×FY 2024: 4750×FY 2025: 4.6×
FY 2017 5y median 26.9× FY 2025
FCF Yield -25.1%
FY 2017: 1.3%FY 2018: -3.3%FY 2019: -3.7%FY 2020: -4.7%FY 2021: -12.9%FY 2022: -13.7%FY 2023: -9.9%FY 2024: -46.1%FY 2025: -25.1%
FY 2017 5y median -13.7% FY 2025

Profitability

Gross Margin 91.1%
FY 2017: -134.4%FY 2018: -30.0%FY 2019: -454.2%FY 2020: -289.6%FY 2021: -240.2%FY 2022: -2464.8%FY 2023: -368.5%FY 2024: -381789.2%FY 2025: 91.1%
FY 2017 5y median -368.5% FY 2025
Operating Margin -187.2%
FY 2017: -194.7%FY 2018: -73.6%FY 2019: -726.7%FY 2020: -416.3%FY 2021: -395.5%FY 2022: -3516.5%FY 2023: -544.6%FY 2024: -507678.4%FY 2025: -187.2%
FY 2017 5y median -544.6% FY 2025
Net Margin -164.4%
FY 2017: -193.8%FY 2018: -67.6%FY 2019: -705.8%FY 2020: -416.5%FY 2021: -395.4%FY 2022: -3435.4%FY 2023: -486.6%FY 2024: -434778.4%FY 2025: -164.4%
FY 2017 5y median -486.6% FY 2025
ROE -27.7%
FY 2017: 57.3%FY 2018: 34.6%FY 2019: 67.6%FY 2020: -22.1%FY 2021: -22.3%FY 2022: -46.5%FY 2023: -32.8%FY 2024: -31.5%FY 2025: -27.7%
FY 2017 5y median -31.5% FY 2025
ROIC -30.2%
FY 2017: -52.2%FY 2018: -11.7%FY 2019: -112.1%FY 2020: -20.9%FY 2021: -21.1%FY 2022: -44.2%FY 2023: -34.8%FY 2024: -35.0%FY 2025: -30.2%
FY 2017 5y median -34.8% FY 2025
ROA -24.7%
FY 2017: -41.1%FY 2018: -9.8%FY 2019: -84.7%FY 2020: -19.7%FY 2021: -20.2%FY 2022: -41.1%FY 2023: -29.7%FY 2024: -28.7%FY 2025: -24.7%
FY 2017 5y median -28.7% FY 2025

Growth (YoY)

Revenue 230194.6%
FY 2017: 0.0%FY 2018: 144.0%FY 2019: -50.6%FY 2020: 94.8%FY 2021: 32.5%FY 2022: -82.7%FY 2023: 562.3%FY 2024: -99.8%FY 2025: 230194.6%
FY 2017 FY 2025
Operating Income 15.1%
FY 2017: 0.0%FY 2018: 7.7%FY 2019: -388.2%FY 2020: -11.6%FY 2021: -25.9%FY 2022: -54.3%FY 2023: -2.6%FY 2024: -66.4%FY 2025: 15.1%
FY 2017 FY 2025
EPS (diluted) 18.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -163.2%FY 2020: -6.0%FY 2021: -16.0%FY 2022: -26.8%FY 2023: 17.3%FY 2024: -15.5%FY 2025: 18.8%
FY 2017 FY 2025
Free Cash Flow 21.2%
FY 2017: 0.0%FY 2018: -317.5%FY 2019: -139.5%FY 2020: -30.1%FY 2021: -50.7%FY 2022: -25.5%FY 2023: 20.0%FY 2024: -76.1%FY 2025: 21.2%
FY 2017 FY 2025

Financial Health

Current Ratio 9.4×
FY 2017: 4.1×FY 2018: 11.7×FY 2019: 4.1×FY 2020: 16.9×FY 2021: 15.7×FY 2022: 14.0×FY 2023: 15.7×FY 2024: 14.9×FY 2025: 9.4×
FY 2017 5y median 14.9× FY 2025
Quick Ratio 9.4×
FY 2017: 4.1×FY 2018: 11.7×FY 2019: 4.1×FY 2020: 16.9×FY 2021: 15.7×FY 2022: 14.0×FY 2023: 15.7×FY 2024: 14.9×FY 2025: 9.4×
FY 2017 5y median 14.9× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 2.2×FY 2018: 9.5×FY 2019: 1.1×FY 2020: 5.0×FY 2021: 2.0×FY 2022: 0.3×FY 2023: 2.5×FY 2024: 0.8×FY 2025: 0.3×
FY 2017 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31